I don't buy the roomie angle. Corx has valuable IP, thus arguably undervalued stock. If neurolixis were to buy corx, current shareholders would be eliminated, and VCs could finance (and reap the profits from) bringing the pipeline to the clinic via partnerships.
The only problem with this scenario is that it's likely illegal.